Free Trial
→ 625,000% Gain (From Crypto Swap Profits) (Ad)

MP Advisors Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at MP Advisors. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by MP Advisors.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$125.30
-0.4%		10/17/2012Target Raised byMP Advisors-Outperform$45.00 -> $50.00N/AView details for MP Advisors rating of Merck & Co., Inc. (NYSE:MRK) on 10/17/2012
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$125.30
-0.4%		7/13/2012Upgraded byMP Advisors-Market Perform -> Outperform$45.00N/AView details for MP Advisors rating of Merck & Co., Inc. (NYSE:MRK) on 7/13/2012
Amgen Inc. stock logo
AMGN
Amgen
$334.85
+0.2%		5/10/2011Target Raised byMP Advisors-Outperform$63.00 -> $65.00N/AView details for MP Advisors rating of Amgen (NASDAQ:AMGN) on 5/10/2011
Biogen Inc. stock logo
BIIB
Biogen
$211.17
-7.2%		4/15/2011Upgraded byMP Advisors-Market Perform -> Outperform$60.00 -> $94.00N/AView details for MP Advisors rating of Biogen (NASDAQ:BIIB) on 4/15/2011
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$1,078.63
+1.4%		4/7/2011Upgraded byMP Advisors-Market Perform -> Outperform$36.00 -> $54.00N/AView details for MP Advisors rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/7/2011
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.15
2/24/2011Initiated byMP Advisors-Market Perform$100.00N/AView details for MP Advisors rating of Protalix BioTherapeutics (NYSE:PLX) on 2/24/2011
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$1,078.63
+1.4%		12/16/2010Downgraded byMP Advisors-Outperform -> Market Perform$34.00 -> $34.00N/AView details for MP Advisors rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 12/16/2010
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$10.75
-1.4%		12/10/2010Downgraded byMP Advisors-Outperform -> Market PerformN/AView details for MP Advisors rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2010

MarketBeat Community Rating for MP Advisors

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  26,649 (Vote Outperform)
Underperform Votes:  23,352 (Vote Underperform)
Total Votes:  50,001
MarketBeat's community ratings are surveys of what our community members think about MP Advisors and other research firms. Vote "Outperform" if you believe MP Advisors's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MP Advisors's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
Today's Ratings:
Top Rated Stocks:
More Ratings Tools: